Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 653


Generation of iPSCs from mouse fibroblasts with a single gene, Oct4, and small molecules.

Li Y, Zhang Q, Yin X, Yang W, Du Y, Hou P, Ge J, Liu C, Zhang W, Zhang X, Wu Y, Li H, Liu K, Wu C, Song Z, Zhao Y, Shi Y, Deng H.

Cell Res. 2011 Jan;21(1):196-204. doi: 10.1038/cr.2010.142.


Optimal reprogramming factor stoichiometry increases colony numbers and affects molecular characteristics of murine induced pluripotent stem cells.

Tiemann U, Sgodda M, Warlich E, Ballmaier M, Schöler HR, Schambach A, Cantz T.

Cytometry A. 2011 Jun;79(6):426-35. doi: 10.1002/cyto.a.21072.


Activation of pluripotency-associated genes in mouse embryonic fibroblasts by non-viral transfection with in vitro-derived mRNAs encoding Oct4, Sox2, Klf4 and cMyc.

Tavernier G, Wolfrum K, Demeester J, De Smedt SC, Adjaye J, Rejman J.

Biomaterials. 2012 Jan;33(2):412-7. doi: 10.1016/j.biomaterials.2011.09.062.


Transient folate deprivation in combination with small-molecule compounds facilitates the generation of somatic cell-derived pluripotent stem cells in mice.

Hu WT, Yan QY, Fang Y, Qiu ZD, Zhang SM.

J Huazhong Univ Sci Technolog Med Sci. 2014 Apr;34(2):151-6. doi: 10.1007/s11596-014-1249-5.


Reprogramming of mouse fibroblasts into induced pluripotent stem cells with Nanog.

Moon JH, Yun W, Kim J, Hyeon S, Kang PJ, Park G, Kim A, Oh S, Whang KY, Kim DW, Yoon BS, You S.

Biochem Biophys Res Commun. 2013 Feb 15;431(3):444-9. doi: 10.1016/j.bbrc.2012.12.149.


Mechanism of Induction: Induced Pluripotent Stem Cells (iPSCs).

Singh VK, Kumar N, Kalsan M, Saini A, Chandra R.

J Stem Cells. 2015;10(1):43-62. Review.


Two-phase analysis of molecular pathways underlying induced pluripotent stem cell induction.

Lin Z, Perez P, Lei D, Xu J, Gao X, Bao J.

Stem Cells. 2011 Dec;29(12):1963-74. doi: 10.1002/stem.752.


Klf4 interacts directly with Oct4 and Sox2 to promote reprogramming.

Wei Z, Yang Y, Zhang P, Andrianakos R, Hasegawa K, Lyu J, Chen X, Bai G, Liu C, Pera M, Lu W.

Stem Cells. 2009 Dec;27(12):2969-78. doi: 10.1002/stem.231.


Direct reprogramming of fibroblasts into epiblast stem cells.

Han DW, Greber B, Wu G, Tapia N, Araúzo-Bravo MJ, Ko K, Bernemann C, Stehling M, Schöler HR.

Nat Cell Biol. 2011 Jan;13(1):66-71. doi: 10.1038/ncb2136.


Manipulation of KLF4 expression generates iPSCs paused at successive stages of reprogramming.

Nishimura K, Kato T, Chen C, Oinam L, Shiomitsu E, Ayakawa D, Ohtaka M, Fukuda A, Nakanishi M, Hisatake K.

Stem Cell Reports. 2014 Nov 11;3(5):915-29. doi: 10.1016/j.stemcr.2014.08.014.


Reprogramming induced pluripotent stem cells in the absence of c-Myc for differentiation into hepatocyte-like cells.

Li HY, Chien Y, Chen YJ, Chen SF, Chang YL, Chiang CH, Jeng SY, Chang CM, Wang ML, Chen LK, Hung SI, Huo TI, Lee SD, Chiou SH.

Biomaterials. 2011 Sep;32(26):5994-6005. doi: 10.1016/j.biomaterials.2011.05.009.


Oct4-enhanced green fluorescent protein transgenic pigs: a new large animal model for reprogramming studies.

Nowak-Imialek M, Kues WA, Petersen B, Lucas-Hahn A, Herrmann D, Haridoss S, Oropeza M, Lemme E, Schöler HR, Carnwath JW, Niemann H.

Stem Cells Dev. 2011 Sep;20(9):1563-75. doi: 10.1089/scd.2010.0399.


Zinc finger nuclease-expressing baculoviral vectors mediate targeted genome integration of reprogramming factor genes to facilitate the generation of human induced pluripotent stem cells.

Phang RZ, Tay FC, Goh SL, Lau CH, Zhu H, Tan WK, Liang Q, Chen C, Du S, Li Z, Tay JC, Wu C, Zeng J, Fan W, Toh HC, Wang S.

Stem Cells Transl Med. 2013 Dec;2(12):935-45. doi: 10.5966/sctm.2013-0043.


Oct4 and klf4 reprogram dermal papilla cells into induced pluripotent stem cells.

Tsai SY, Clavel C, Kim S, Ang YS, Grisanti L, Lee DF, Kelley K, Rendl M.

Stem Cells. 2010 Feb;28(2):221-8. doi: 10.1002/stem.281.


Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors.

Kim JB, Zaehres H, Wu G, Gentile L, Ko K, Sebastiano V, Araúzo-Bravo MJ, Ruau D, Han DW, Zenke M, Schöler HR.

Nature. 2008 Jul 31;454(7204):646-50. doi: 10.1038/nature07061.


Global transcriptional analysis of nuclear reprogramming in the transition from MEFs to iPSCs.

Dong F, Song Z, Zhang J, Lu Y, Song C, Jiang B, Zhang B, Cong P, Sun H, Shi F, Liu H.

Genes Cells. 2013 Jan;18(1):42-55. doi: 10.1111/gtc.12017.


Reprogramming human endometrial fibroblast into induced pluripotent stem cells.

Chen YJ, Liou YJ, Chang CM, Li HY, Chen CY, Twu NF, Yen MS, Chang YL, Peng CH, Chiou SH, Chen CP, Chao KC.

Taiwan J Obstet Gynecol. 2012 Mar;51(1):35-42. doi: 10.1016/j.tjog.2012.01.008.


Generation of disease-specific induced pluripotent stem cells from patients with different karyotypes of Down syndrome.

Mou X, Wu Y, Cao H, Meng Q, Wang Q, Sun C, Hu S, Ma Y, Zhang H.

Stem Cell Res Ther. 2012 Apr 18;3(2):14. doi: 10.1186/scrt105.


Reprogramming in vivo produces teratomas and iPS cells with totipotency features.

Abad M, Mosteiro L, Pantoja C, Cañamero M, Rayon T, Ors I, Graña O, Megías D, Domínguez O, Martínez D, Manzanares M, Ortega S, Serrano M.

Nature. 2013 Oct 17;502(7471):340-5. doi: 10.1038/nature12586.

Items per page

Supplemental Content

Support Center